Molecules/POLATUZUMAB VEDOTIN

POLATUZUMAB VEDOTIN

CHEMBL3301582

Compare

Molecular Identity

POLATUZUMAB VEDOTIN

ChEMBL ID: CHEMBL3301582

Antibody drug conjugateApprovedFirst approved 2019

Mechanism of action: B-cell antigen receptor complex-associated protein beta chain binding agent

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(19)

ACD-79B-VCMMAEACD-79BVCMMAEACD79B-VCMMAEANTI-CD79B ADCDCDS-4501ADCDS4501AFCU-2711FCU2711POLATUZUMAB VEDOTINPOLATUZUMAB VEDOTINAPOLATUZUMAB VEDOTINEPOLATUZUMAB VEDOTIN PIIQPOLATUZUMAB VEDOTIN-PIIQPolivyRG-7596

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to POLATUZUMAB VEDOTIN

Loading drug network...